版本:
中国

BRIEF-U.S. FDA says granted approval of Brineura to Biomarin Pharmaceutical

April 27 U.S. Food and Drug Administration :

* FDA approves first treatment for a form of batten disease

* Granted approval of Brineura to Biomarin Pharmaceutical Inc

* Will require Biomarin Pharmaceutical Inc to further evaluate the safety of Brineura in CLN2 patients below the age of 2 years Source text : (bit.ly/2oQ3x55) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐